MELK, a highly conserved serine/threonine kinase, has been reported to be highly expressed in various types of human malignancies and exert an oncogenic role through modulating cell proliferation, apoptosis, cancer stem cell phenotypes, EMT, metastasis and treatment resistance [41]. The gene discussed is MELK; the disease is cancer.